Pitcairn CO Merck & Co., Inc. Transaction History

Pitcairn CO

$1.63 Billion
Q1 2025

A detailed history of Pitcairn CO transactions in Merck & Co., Inc. stock. As of the latest transaction made, Pitcairn CO holds 18,704 shares of MRK stock, worth $1.42 Million. This represents 0.1% of its overall portfolio holdings.

Number of Shares

18,704

Previous 21,969 14.86%

Holding current value

$1.42 Million

Previous $2.19 Million 23.2%

% of portfolio

0.1%

Previous 0.13%

31 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 09, 2025	SELL	$83.01 - $101.02 $271,027 - $329,830	-3,265 Reduced 14.86%	18,704 $1.68 Million
Q4 2024 Feb 12, 2025	BUY	$96.31 - $114.76 $33,997 - $40,510	353 Added 1.63%	21,969 $2.19 Million
Q3 2024 Nov 12, 2024	SELL	$111.15 - $128.97 $436,486 - $506,465	-3,927 Reduced 15.37%	21,616 $2.45 Million
Q2 2024 Aug 13, 2024	BUY	$123.8 - $132.96 $242,400 - $260,335	1,958 Added 8.3%	25,543 $3.16 Million
Q1 2024 May 13, 2024	BUY	$113.24 - $131.95 $88,213 - $102,789	779 Added 3.42%	23,585 $3.11 Million
Q4 2023 Feb 14, 2024	SELL	$100.18 - $109.02 $20,236 - $22,022	-202 Reduced 0.88%	22,806 $2.49 Million
Q3 2023 Nov 13, 2023	BUY	$102.95 - $114.33 $121,275 - $134,680	1,178 Added 5.4%	23,008 $2.37 Million
Q2 2023 Aug 11, 2023	BUY	$108.61 - $118.38 $20,635 - $22,492	190 Added 0.88%	21,830 $2.52 Million
Q1 2023 May 05, 2023	BUY	$102.94 - $114.86 $82,969 - $92,577	806 Added 3.87%	21,640 $2.3 Million
Q4 2022 Feb 13, 2023	BUY	$87.44 - $112.11 $79,570 - $102,020	910 Added 4.57%	20,834 $2.31 Million
Q3 2022 Nov 10, 2022	SELL	$84.53 - $94.96 $47,505 - $53,367	-562 Reduced 2.74%	19,924 $1.72 Million
Q2 2022 Aug 12, 2022	BUY	$83.49 - $94.64 $107,368 - $121,707	1,286 Added 6.7%	20,486 $1.87 Million
Q1 2022 May 12, 2022	SELL	$73.51 - $82.4 $241,847 - $271,096	-3,290 Reduced 14.63%	19,200 $1.58 Million
Q4 2021 Feb 14, 2022	SELL	$72.28 - $90.54 $529,667 - $663,477	-7,328 Reduced 24.58%	22,490 $1.72 Million
Q3 2021 Nov 10, 2021	SELL	$71.68 - $78.83 $317,040 - $348,665	-4,423 Reduced 12.92%	29,818 $2.24 Million
Q2 2021 Aug 11, 2021	BUY	$70.31 - $77.77 $30,162 - $33,363	429 Added 1.27%	34,241 $2.66 Million
Q1 2021 May 10, 2021	BUY	$68.86 - $81.11 $277,574 - $326,954	4,031 Added 13.54%	33,812 $2.61 Million
Q4 2020 Feb 05, 2021	SELL	$71.77 - $79.65 $69,903 - $77,579	-974 Reduced 3.17%	29,781 $2.44 Million
Q3 2020 Nov 03, 2020	SELL	$73.18 - $82.95 $261,472 - $296,380	-3,573 Reduced 10.41%	30,755 $2.55 Million
Q2 2020 Jul 28, 2020	SELL	$70.42 - $80.13 $5,844 - $6,650	-83 Reduced 0.24%	34,328 $2.65 Million
Q1 2020 May 13, 2020	SELL	$63.36 - $87.82 $57,277 - $79,389	-904 Reduced 2.56%	34,411 $2.65 Million
Q4 2019 Feb 12, 2020	SELL	$77.58 - $87.54 $379,521 - $428,245	-4,892 Reduced 12.17%	35,315 $3.21 Million
Q3 2019 Nov 12, 2019	SELL	$76.08 - $82.93 $117,163 - $127,712	-1,540 Reduced 3.69%	40,207 $3.39 Million
Q2 2019 Aug 12, 2019	BUY	$69.84 - $81.59 $38,062 - $44,466	545 Added 1.32%	41,747 $3.5 Million
Q1 2019 May 07, 2019	SELL	$69.58 - $79.36 $86,835 - $99,041	-1,248 Reduced 2.94%	41,202 $3.43 Million
Q4 2018 Feb 12, 2019	BUY	$65.24 - $75.71 $1.37 Million - $1.59 Million	20,974 Added 97.66%	42,450 $3.24 Million
Q3 2018 Nov 02, 2018	BUY	$57.69 - $67.84 $72,054 - $84,732	1,249 Added 6.17%	21,476 $1.52 Million
Q2 2018 Aug 02, 2018	SELL	$50.83 - $59.72 $19,722 - $23,171	-388 Reduced 1.88%	20,227 $1.23 Million
Q1 2018 May 11, 2018	SELL	$50.96 - $59.23 $104,162 - $121,066	-2,044 Reduced 9.02%	20,615 $1.12 Million
Q4 2017 Feb 13, 2018	SELL	$51.62 - $61.64 $22,609 - $26,998	-438 Reduced 1.9%	22,659 $1.28 Million
Q3 2017 Nov 03, 2017	BUY	$58.67 - $63.13 $1.36 Million - $1.46 Million	23,097	23,097 $1.48 Million

Others Institutions Holding MRK

# of Institutions

3,894

Shares Held

1.93B

Call Options Held

26.2M

Put Options Held

23.5M

View Full List

About Merck & Co., Inc.

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $193B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

More about MRK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Pitcairn CO, based on Form 13F filings with the SEC.

News

Stay updated on Pitcairn CO with notifications on news.

Account